BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28
18 results:

  • 1. Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of
    Gheorghe AM; Sima OC; Florescu AF; Ciuche A; Nistor C; Sandru F; Carsote M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396977
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A family case report of parathyroid carcinoma associated with
    Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
    Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
    Tora R; Welch J; Sun J; Agarwal SK; Bell DA; Merino M; Weinstein LS; Simonds WF; Jha S
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3165-3177. PubMed ID: 37339334
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Rare duplication of the cdc73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.
    Garrigues G; Batisse-Lignier M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Kelly A; Gay-Bellile M; Viala S; Bidet Y; Bignon YJ; Cavaillé M
    Mol Genet Genomic Med; 2023 May; 11(5):e2133. PubMed ID: 36639964
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Benign polypoid adenomyomatous endometrium associated with hpt-jt syndrome: a case report.
    Arfi A; Chabbert-Buffet N; Boudy AS; de Foucher T; Owen C; Bendifallah S; Darai E
    Gynecol Endocrinol; 2020 Jan; 36(1):30-32. PubMed ID: 31429335
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Familial Kidney cancer: Implications of New Syndromes and Molecular Insights.
    Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
    Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hyper Parathyroidisim Jaw Tumor Syndrome: A Rare Condition of Incongruous Features.
    Redwin Dhas MP; Karthiga KS; Tatu JE; Eugenia SJ
    Ethiop J Health Sci; 2017 May; 27(3):309-313. PubMed ID: 29217931
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. cdc73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
    van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Large intragenic deletion of cdc73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (hpt-jt) syndrome family.
    Guarnieri V; Seaberg RM; Kelly C; Jean Davidson M; Raphael S; Shuen AY; Baorda F; Palumbo O; Scillitani A; Hendy GN; Cole DEC
    BMC Med Genet; 2017 Aug; 18(1):83. PubMed ID: 28774260
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel cdc73 mutation.
    Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
    Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Frequent large germline hrpt2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Aromatase inhibitor treatment of menorrhagia and subsequent pregnancy in a patient with familial hyperparathyroidism-jaw tumor syndrome.
    Wolff EF; Hill MJ; Simonds WF; Segars JH
    Fertil Steril; 2012 Dec; 98(6):1616-9. PubMed ID: 22963808
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. cdc73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum.
    Frank-Raue K; Haag C; Schulze E; Keuser R; Raue F; Dralle H; Lorenz K
    Eur J Endocrinol; 2011 Sep; 165(3):477-83. PubMed ID: 21652691
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hyperparathyroidism-jaw tumor syndrome: a case report.
    Rekik N; Ben Naceur B; Mnif M; Mnif F; Mnif H; Boudawara T; Abid M
    Ann Endocrinol (Paris); 2010 Mar; 71(2):121-6. PubMed ID: 19942209
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
    Iacobone M; Masi G; Barzon L; Porzionato A; Macchi V; Ciarleglio FA; Palù G; De Caro R; Viel G; Favia G
    Langenbecks Arch Surg; 2009 Sep; 394(5):817-25. PubMed ID: 19529956
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical, genetic, and histopathologic investigation of cdc73-related familial hyperparathyroidism.
    Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
    Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immunohistochemical assessment of parafibromin in mouse and human tissues.
    Porzionato A; Macchi V; Barzon L; Masi G; Iacobone M; Parenti A; Palù G; De Caro R
    J Anat; 2006 Dec; 209(6):817-27. PubMed ID: 17118068
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome.
    Bradley KJ; Hobbs MR; Buley ID; Carpten JD; Cavaco BM; Fares JE; Laidler P; Manek S; Robbins CM; Salti IS; Thompson NW; Jackson CE; Thakker RV
    J Intern Med; 2005 Jan; 257(1):18-26. PubMed ID: 15606373
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.